je.st
news
Tag: present
Realtor Brian Bartholomew to Present $3,000 in Backpacks and Holiday...
2015-10-26 21:42:34| Real Estate - Topix.net
To support Fullerton special education programs, Brian Bartholomew, local Real Estate Agent and Fullerton Cares Board Director, is getting in the holiday spirit, giving 137 backpacks, valued at over $3,000, to assist students and families with autism in the Fullerton School District.
Tags: present
holiday
brian
realtor
MSD Animal Health to Present Important New Data at 7th Asian Pig Veterinary Society Congress
2015-10-26 01:00:00| ThePigSite - Industry News
PHILIPPINES - Respiratory and Reproduction Data Top List of Presentations.
Tags: data
health
important
present
Lattice Semiconductor to Present at Jefferies West Coast SMID Cap Summit
2015-10-24 06:30:26| Semiconductors - Topix.net
Lattice Semiconductor Corporation today announced that it is scheduled to present at Jefferies West Coast SMID Cap Summit taking place on Wednesday, November 4 at the Hotel Vitale in San Francisco. During the conference, Joe Bedewi, Corporate Vice President and Chief Financial Officer, and Khurram Sheikh, Chief Strategy and Technology Officer, President SiBEAM, will be presenting.
Galena Biopharma to Present GALE-302 Preliminary Immunological Data...
2015-10-22 21:17:07| Biotech - Topix.net
Galena Biopharma to Present GALE-302 Preliminary Immunological Data Optimizing GALE-301, and the Phase 2 NeuVax Data Impact on Cancer Survivorship at Two Upcoming Medical Conferences SAN RAMON, Calif., Oct. 22, 2015 -- Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that data from the Company's NeuVax and GALE-301 and GALE-302 clinical programs will be presented at two upcoming medical conferences.
Tags: data
present
preliminary
immunological
Merck to Present New Data on Investigational Chronic Hepatitis C Treatment Elbasvir/Grazoprevir at The Liver Meeting 2015, Including Phase 3 Results in Selected Difficult-to-Treat Populations
2015-10-20 16:35:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. New Data Will Also be Presented from Phase 2a C-CREST Trials of Mercks Investigational Triple-Combination Chronic Hepatitis C Therapies KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data from clinical trials of its investigational treatment portfolio for chronic hepatitis C virus (HCV) are scheduled to be presented at The Liver Meeting 2015 (the 66th annual scientific congress of the American Association for the Study of Liver Diseases) in San Francisco, from Nov. 13-17, 2015. Mercks late-stage investigational portfolio includes elbasvir/grazoprevir1, MK-36822 and MK-84083. Language: English Contact: MerckMedia:Doris Li, 908-246-5701Sarra Herzog, 908-740-1871orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
including
data
present
Sites : [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] next »